Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures

[1]  R. Recker,et al.  Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis , 1996 .

[2]  B. Adams-Huet,et al.  Treatment of Postmenopausal Osteoporosis with Slow-Release Sodium Fluoride: Final Report of a Randomized Controlled Trial , 1995, Annals of Internal Medicine.

[3]  Robert Epstein,et al.  Comparison of methods for defining prevalent vertebral deformities: The study of osteoporotic fractures , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  S. Greenspan,et al.  Femoral bone loss progresses with age: A longitudinal study in women over age 65 , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  C. Cooper,et al.  Risk of hip fracture in women with vertebral fracture , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  H. Genant,et al.  Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy. , 1993, The American journal of medicine.

[7]  M. Nevitt,et al.  Vertebral fracture assessment using a semiquantitative technique , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  H. Kang,et al.  Vertebral Fracture in Osteoporosis , 1993 .

[9]  Caroline S. Fox,et al.  Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women , 1992, Annals of Internal Medicine.

[10]  F Duboeuf,et al.  Vitamin D3 and calcium to prevent hip fractures in elderly women. , 1992, The New England journal of medicine.

[11]  M. A. Hansen,et al.  Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study. , 1992, BMJ.

[12]  L. Melton,et al.  The prevention and treatment of osteoporosis. , 1992, The New England journal of medicine.

[13]  A. Lane,et al.  Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen , 1992, Annals of Internal Medicine.

[14]  G. Spears,et al.  Treatment of postmenopausal osteoporosis with calcitriol or calcium. , 1992, The New England journal of medicine.

[15]  S. Cummings,et al.  Which Fractures Are Associated with Low Appendicular Bone Mass in Elderly Women , 1991 .

[16]  R. Epstein,et al.  Pre-existing fractures and bone mass predict vertebral fracture incidence in women. , 1991, Annals of internal medicine.

[17]  W. O'Fallon,et al.  Risk of hip fracture among women with vertebral fractures , 1990 .

[18]  W. Mysiw,et al.  Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. , 1990, The New England journal of medicine.

[19]  H. Genant,et al.  Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. , 1990, The New England journal of medicine.

[20]  S. Cummings,et al.  Lifetime risks of hip, Colles', or vertebral fracture and coronary heart disease among white postmenopausal women. , 1989, Archives of internal medicine.

[21]  S. H. Kan,et al.  Epidemiology of vertebral fractures in women. , 1989, American journal of epidemiology.

[22]  D. Kiel,et al.  Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. , 1987, The New England journal of medicine.

[23]  G Block,et al.  Evaluation of two food frequency methods of measuring dietary calcium intake. , 1987, American journal of epidemiology.

[24]  R. Lindsay,et al.  Long term effect of oestrogen replacement therapy on bone mass as measured by dual photon absorptiometry. , 1987, British medical journal.

[25]  D. Cox,et al.  Analysis of Survival Data. , 1985 .

[26]  W. O'Fallon,et al.  Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. , 1982, The New England journal of medicine.